Why Is HIMS & HERS HEALTH I A (HIMS) Stock Down Today?

Why HIMS stock is down today

Hims & Hers Health stock fell 7.99% to $31.08 in a session marked by mounting regulatory and financial pressures. The decline followed reports that Visa may impose penalties over billing disputes tied to the company’s weight-loss subscription services. These developments coincided with a securities fraud investigation and a recent FTC lawsuit, compounding investor concerns.

What Happened

The stock’s sharp drop came amid multiple overlapping issues. Visa reportedly placed Hims & Hers into its Acquirer Monitoring Program due to a spike in billing disputes, which could lead to additional costs and reputational damage. This followed a Bloomberg report confirming the same issue, and the company is already facing a lawsuit from the Federal Trade Commission. In addition, the Law Offices of Frank R. Cruz is investigating the company for potential securities fraud, urging affected shareholders to contact its firm. Meanwhile, Truist raised its price target to $32 from $27, but this positive move was overshadowed by the broader negative news.

What The Data Shows

Despite the recent price drop, the stock has risen 4.6% over the last eight sessions, moving from $29.70 to $31.08. The stock hit a fresh 52-week low on August 25, 2026, with 15 such prints recorded that day. Options activity showed unusual volume, with $970,000 in call premiums and $561,000 in put premiums exchanged, the largest single print being $561,000. Insiders have sold more than they have bought in the last 90 days, with 11 sales totaling $7.2 million and only one purchase totaling $1.2 million.

What To Watch

The stock’s near-term direction may depend on the outcome of the ongoing regulatory scrutiny and the company’s response to the billing dispute allegations. Investors should also monitor the company’s next earnings report if one is scheduled.